![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 15575-15580, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Transport and utilization of fatty acids
(FA) in cells is a multistep process that includes adsorption to and
movement across the plasma membrane and binding to intracellular fatty
acid binding proteins (FABP) in the cytosol. We monitored the
transbilayer movement of several polyunsaturated FA and
oxidation products (13-hydroxy octadecadienoic acid (HODE) and
15-hydroxytetraenoic acid (HETE)) in unilamellar protein-free
phospholipid vesicles containing a fluorescent pH probe. All FA
diffused rapidly by the flip-flop mechanism across the model membrane,
as revealed by pH changes inside the vesicle. This result suggests that
FA oxidation products generated in the cell could cross the plasma or
nuclear membrane spontaneously without a membrane transporter. To illuminate features of extra- and intracellular transport, the partitioning of unsaturated FA and oxidized FA between phospholipid vesicles and albumin or FABP was studied by the pyranin assay. These
experiments showed that all polyunsaturated FA and oxidized FA (13-HODE
and 15-HETE) desorbed rapidly from the phospholipid bilayer to bind to
bovine serum albumin, which showed a slight preference for the
unsaturated FA over the oxidized FA. FABP rapidly bound FA in the
presence of phospholipid bilayers, with a preference of 13-HODE over
the unsaturated FA and with a specificity depending on the type of
FABP. Liver FABP was significantly more effective than intestinal FABP
in binding 13-HODE in the presence of vesicles. The more effective
binding of the FA metabolite, 13-HODE, than its precursor 18:2 by FABP
may help protect cellular membranes from potential damage by
monohydroxy fatty acids and may contribute a pathway for entry of
13-HODE into the nucleus.
Binding of 13-HODE and 15-HETE to Phospholipid Bilayers,
Albumin, and Intracellular Fatty Acid Binding Proteins
IMPLICATIONS FOR TRANSMEMBRANE AND INTRACELLULAR
TRANSPORT AND FOR PROTECTION FROM LIPID PEROXIDATION*
,
Departments of Preclinical Research
and Development, Astrazeneca, 431 83 Mölndal, Sweden and the
§ Department of Biophysics, Boston University School of
Medicine, Boston, Massachusetts 02118
*
This work was supported in part by National Institutes of
Health Grant HL26635 (to J. A. H.)The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. Kamijo-Ikemori, T. Sugaya, A. Obama, J. Hiroi, H. Miura, M. Watanabe, T. Kumai, R. Ohtani-Kaneko, K. Hirata, and K. Kimura Liver-Type Fatty Acid-Binding Protein Attenuates Renal Injury Induced by Unilateral Ureteral Obstruction Am. J. Pathol., October 1, 2006; 169(4): 1107 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Carrier, G. Deblois, C. Champigny, E. Levy, and V. Giguere Estrogen-related Receptor {alpha} (ERR{alpha}) Is a Transcriptional Regulator of Apolipoprotein A-IV and Controls Lipid Handling in the Intestine J. Biol. Chem., December 10, 2004; 279(50): 52052 - 52058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luo, S. M. Jones, M. Peters-Golden, and T. G. Brock Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity PNAS, October 14, 2003; 100(21): 12165 - 12170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |